Strzelczyk A, Reese JP, Dodel R, Hamer HM (2008) Cost of epilepsy: A systematic review. PharmacoEconomics 26:463–476
Willems LM, Zöllner JP, Hamann L, Knake S, Kovac S, von Podewils F, Rosenow F, Strzelczyk A (2023) Unemployment and early retirement among patients with epilepsy—A study on predictors, resilience factors and occupational reintegration measures. Epilepsy Behav 144:109255
Yu X, Lim KS, Tang LY, David P, Ong ZQ, Wong KY, Ji M (2025) Caregiving burden for adults with epilepsy and coping strategies, a systematic review. Epilepsy Behav 164:110262
Willems LM, Hochbaum M, Frey K, Schulz J, Menzler K, Langenbruch L, Kovac S, Immisch I, von Podewils F, Hamacher M, Siebenbrodt K, Rosenow F, Reese JP, Strzelczyk A (2022) Multicenter, cross-sectional study of the costs of illness and cost-driving factors in adult patients with epilepsy. Epilepsia 63:904–918
Riechmann J, Strzelczyk A, Reese JP, Boor R, Stephani U, Langner C, Neubauer BA, Oberman B, Philippi H, Rochel M, Seeger J, Seipelt P, Oertel WH, Dodel R, Rosenow F, Hamer HM, EpiPaed Study G (2015) Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany. Epilepsia 56:1388–1397
Strzelczyk A, Griebel C, Lux W, Rosenow F, Reese J‑P (2017) The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use and cost using German Health insurance data. Front Neurol 8:712
Willems LM, Hochbaum M, Zöllner JP, Schulz J, Menzler K, Langenbruch L, Kovac S, Knake S, von Podewils F, Hamacher M, Hamer HM, Reese JP, Frey K, Rosenow F, Strzelczyk A (2022) Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020. Epilepsia 63:1591–1602
Willems LM, Richter S, Watermann N, Bauer S, Klein KM, Reese JP, Schöffski O, Hamer HM, Knake S, Rosenow F, Strzelczyk A (2018) Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013—A ten-year overview. Epilepsy Behav 83:28–35
Strzelczyk A, Brunklaus A, Rosenow F, Paprocka J, Schubert-Bast S, Kämppi L (2024) Cost-of-illness review of status epilepticus in Europe. Epilepsy Behav. 161:110105
Pato Pato A, Perez CE, Cimas HI, Gonzalez LJR, Rodriguez Constenla I, Gude Sampedro F (2011) Analysis of direct, indirect, and intangible costs of epilepsy. Neurologia 26:32–38
Article CAS PubMed Google Scholar
Wundes A, Brown T, Bienen EJ, Coleman CI (2010) Contribution of intangible costs to the economic burden of multiple sclerosis. J Med Econ 13:626–632
Kitschen A, Aleknonyte-Resch M, Sakalyte G, Diederich F (2023) Cost-effectiveness of surgical treatment compared to medical treatment in patients with drug-refractory epilepsy: A systematic review. Eur J Neurol 30:749–761
Sheikh SR, Kattan MW, Steinmetz M, Singer ME, Udeh BL, Jehi L (2020) Cost-effectiveness of surgery for drug-resistant temporal lobe epilepsy in the US. Neurology 95:e1404–e1416
Picot MC, Jaussent A, Neveu D, Kahane P, Crespel A, Gelisse P, Hirsch E, Derambure P, Dupont S, Landre E, Chassoux F, Valton L, Vignal JP, Marchal C, Lamy C, Semah F, Biraben A, Arzimanoglou A, Petit J, Thomas P, Macioce V, Dujols P, Ryvlin P (2016) Cost-effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: A 5-year follow-up study. Epilepsia 57:1669–1679
Kohlhase K, Strzelczyk A, Porto L, Beißel A, Curry DJ, Rosenow F, Schubert-Bast S (2021) MR-gestützte stereotaktische Laserthermoablation eines hypothalamischen Hamartoms bei einer jungen Epilepsiepatientin: klinischer Verlauf und Kostenanalyse. Z Epileptol 34:324–330
Holtkamp M, May TW, Berkenfeld R, Bien CG, Coban I, Knake S, Michaelis R, Rémi J, Seeck M, Surges R, Weber Y, Baum P, Baumgartner C, Beyenburg S, Brandt C, Brodisch P, Brückner S, Chatzikonstantinou A, Conrad S, Fauser S, Focke N, Freiman T, Freitag H, Fudali M, Geiger-Riess M, Greshake B, Grimmer A, Hebel J, Held L, Kaufmann E, Kerling F, Knieß T, Kollmar R, Krämer G, Kürsten K, Laufs H, Lüsebrink A, Lutz M, Möddel G, Müffelmann B, Noachtar S, Rösche J, Rozinat K, Rüegg S, Schäfer U, Schmidt PM, Schmitt FC, Schmitt J, Schneider UC, Schulze-Bonhage A, Speicher P, Strzelczyk A, Stutterheim K, Thorbecke R, Trollmann R, Urbach H, von Oertzen TJ, von Podewils F, von Wrede R, Wagner K, Weber R, Wehner T, Wendtland F, Winter Y, Woermann F, Zieglgänsberger D (2024) Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. Clin Epileptol 37:118–139
Mann L, Rosenow F, Strzelczyk A, Hattingen E, Willems LM, Harter PN, Weber K, Mann C (2023) The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis. Neurol Res Pract 5:65
Article PubMed PubMed Central Google Scholar
Cloppenborg T, Bien C (2023) Trends in der prächirurgischen Diagnostik und der operativen Epilepsiebehandlung. Clin Epileptol 36:85–90
Engelgeer A, van Westrhenen A, Thijs RD, Evers S (2022) An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utility. Seizure 101:156–161
Braithwaite RS, Meltzer DO, King JT Jr., Leslie D, Roberts MS (2008) What does the value of modern medicine say about the $ 50,000 per quality-adjusted life-year decision rule? Med Care 46:349–356
Siebenbrodt K, Willems LM, von Podewils F, Mross PM, Strüber M, Langenbruch L, Bierhansl L, Gorny I, Schulz J, Gaida B, Conradi N, Süss A, Rosenow F, Strzelczyk A (2023) Determinants of quality of life in adults with epilepsy: a multicenter, cross-sectional study from Germany. Neurol Res Pract 5:41
Article PubMed PubMed Central Google Scholar
Engel JVNPJ, Rasmussen TB, Ojemann LM (1993) Outcome with respect to epileptic seizures. Raven Press, New York
Sanchez Fernandez I, Amengual-Gual M, Barcia Aguilar C, Romeu A, Jonas R, Torres A, Gainza-Lein M, Douglass L (2023) Health care resource utilization and costs before and after epilepsy surgery. Seizure 104:22–31
Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S (2007) Health care costs decline after successful epilepsy surgery. Neurology 68:1290–1298
Article CAS PubMed Google Scholar
Meints SM, Edwards RR (2018) Evaluating psychosocial contributions to chronic pain outcomes. Prog Neuropsychopharmacol Biol Psychiatry 87:168–182
Article CAS PubMed PubMed Central Google Scholar
Lappe L, Hertzberg C, Knake S, Knuf M, von Podewils F, Willems LM, Kovac S, Zöllner JP, Sauter M, Kurlemann G, Mayer T, Bertsche A, Marquard K, Meyer S, Schäfer H, Thiels C, Zukunft B, Schubert-Bast S, Reese JP, Rosenow F, Strzelczyk A (2024) A multicenter, matched case-control analysis comparing burden of illness among patients with tuberous sclerosis complex related epilepsy, generalized idiopathic epilepsy, and focal epilepsy in Germany. Neurol Res Pract 6:29
Article PubMed PubMed Central Google Scholar
Mann C, Conradi N, Freiman TM, Spyrantis A, Konczalla J, Hattingen E, Wagner M, Harter PN, Mueller M, Leyer AC, Reif PS, Bauer S, Schubert-Bast S, Strzelczyk A, Rosenow F (2021) Postoperative outcomes and surgical ratio at a newly established epilepsy center: The first 100 procedures. Epilepsy Behav 116:107715
Thorbecke R, May TW, Koch-Stoecker S, Ebner A, Bien CG, Specht U (2014) Effects of an inpatient rehabilitation program after temporal lobe epilepsy surgery and other factors on employment 2 years after epilepsy surgery. Epilepsia 55:725–733
Willems LM, Reif PS, Knake S, Hamer HM, Willems C, Krämer G, Rosenow F, Strzelczyk A (2018) Noncompliance of patients with driving restrictions due to uncontrolled epilepsy. Epilepsy Behav 91:86–89
Helmstaedter C, Elger CE, Witt JA (2016) The effect of quantitative and qualitative antiepileptic drug changes on cognitive recovery after epilepsy surgery. Seizure 36:63–69
Willems LM, van der Goten M, von Podewils F, Knake S, Kovac S, Zöllner JP, Rosenow F, Strzelczyk A (2023) Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy CNS Drugs 37(6):531–544
Helmstaedter C, Elger CE, Vogt VL (2018) Cognitive outcomes more than 5 years after temporal lobe epilepsy surgery: Remarkable functional recovery when seizures are controlled. Seizure 62:116–123
Article CAS PubMed Google Scholar
Gao L, Xia L, Pan SQ, Xiong T, Li SC (2015) Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy. Epilepsy Res 110:146–156
Willems LM, Knake S, Rosenow F, Reese JP, Conradi N, Strzelczyk A (2022) EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy. Epilepsy Behav 127:108554
Devinsky O, Barr WB, Vickrey BG, Berg AT, Bazil CW, Pacia SV, Langfitt JT, Walczak TS, Sperling MR, Shinnar S, Spencer SS (2005) Changes in depression and anxiety after resective surgery for epilepsy. Neurology 65:1744–1749
Article CAS PubMed Google Scholar
Hamid H, Liu H
Comments (0)